Drug Side Effects

Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

Poly(ADP-Ribose) Polymerase Inhibitor [EPC] was reported 29050 times

Drugs of the Poly(ADP-Ribose) Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CARBOHYDRATE ANTIGEN 125 INCREASED 1918 0.6332
1 CARBOHYDRATE ANTIGEN 125 10 0.5000
2 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS 37 0.5000
3 OVARIAN CANCER RECURRENT 468 0.4597
4 ACUTE ERYTHROID LEUKAEMIA 14 0.4516
5 BRCA2 GENE MUTATION 19 0.2639
6 RECURRENT CANCER 690 0.2256
7 SCAN ABNORMAL 51 0.1932
8 BRCA1 GENE MUTATION 10 0.1887
9 DRUG MONITORING PROCEDURE NOT PERFORMED 241 0.1783
10 POSITRON EMISSION TOMOGRAM ABNORMAL 79 0.1763
11 LYMPHANGIOLEIOMYOMATOSIS 15 0.1705
12 ACUTE MEGAKARYOCYTIC LEUKAEMIA 9 0.1698
13 LYMPH NODES SCAN ABNORMAL 17 0.1604
14 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 133 0.1595
15 LIVER SCAN ABNORMAL 20 0.1449
16 TUMOUR MARKER ABNORMAL 30 0.1176
17 TUMOUR MARKER INCREASED 400 0.1095
18 INTENTIONAL UNDERDOSE 658 0.1070
19 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 47 0.0973
20 CORONAVIRUS TEST POSITIVE 83 0.0937
21 OVARIAN CANCER METASTATIC 64 0.0929
22 MALIGNANT PERITONEAL NEOPLASM 45 0.0918
23 FALLOPIAN TUBE CANCER 10 0.0909
24 COMPUTERISED TOMOGRAM ABNORMAL 172 0.0852
25 FLUID REPLACEMENT 21 0.0830
26 TUMOUR MARKER DECREASED 10 0.0794
27 WHITE COAT HYPERTENSION 22 0.0677
28 PELVIC NEOPLASM 17 0.0623
29 METASTASES TO ABDOMINAL CAVITY 25 0.0620
30 DECREASED ACTIVITY 499 0.0600
31 OVARIAN CANCER STAGE III 19 0.0579
32 RED BLOOD CELL COUNT DECREASED 1244 0.0535
33 MEAN CELL HAEMOGLOBIN INCREASED 62 0.0522
34 METASTASES TO PELVIS 24 0.0502
35 OVARIAN CANCER STAGE IV 18 0.0490
36 INTESTINAL METASTASIS 11 0.0468
37 MEAN CELL VOLUME ABNORMAL 17 0.0464
38 MEAN CELL VOLUME INCREASED 87 0.0464
39 OVARIAN CANCER 365 0.0456
40 METASTASES TO PERITONEUM 85 0.0451
41 CENTRAL VENOUS CATHETER REMOVAL 16 0.0442
42 PLATELET COUNT DECREASED 3628 0.0422
43 RED BLOOD CELL COUNT ABNORMAL 47 0.0420
44 URETERAL STENT INSERTION 10 0.0408
45 FULL BLOOD COUNT ABNORMAL 277 0.0400
46 BLAST CELLS PRESENT 16 0.0392
47 PRODUCT DOSE OMISSION IN ERROR 365 0.0370
48 ABDOMINAL CAVITY DRAINAGE 14 0.0369
49 NEUTROPHIL PERCENTAGE DECREASED 15 0.0361
50 MYELODYSPLASTIC SYNDROME 430 0.0359
51 ABDOMINAL NEOPLASM 27 0.0356
52 BLOOD CREATINE ABNORMAL 13 0.0355
53 PELVIC MASS 24 0.0352
54 ACQUIRED GENE MUTATION 33 0.0339
55 BLOOD MAGNESIUM DECREASED 227 0.0336
56 MALIGNANT NEOPLASM PROGRESSION 2554 0.0330
57 METASTASES TO SPLEEN 11 0.0319
58 PLATELET DISORDER 65 0.0319
59 MALIGNANT ASCITES 19 0.0305
60 BLOOD COUNT ABNORMAL 469 0.0303
61 PRODUCT MONITORING ERROR 38 0.0287
62 RED CELL DISTRIBUTION WIDTH INCREASED 88 0.0274
63 ACUTE MYELOID LEUKAEMIA 339 0.0274
64 CORONAVIRUS INFECTION 138 0.0268
65 NEOPLASM RECURRENCE 72 0.0266
66 TASTE DISORDER 309 0.0263
67 CARBOHYDRATE ANTIGEN 19-9 INCREASED 10 0.0259
68 RED BLOOD CELL ABNORMALITY 21 0.0258
69 BRAIN FOG 29 0.0242
70 ASPIRATION PLEURAL CAVITY 16 0.0235
71 METASTASES TO PLEURA 18 0.0235
72 PHOTOSENSITIVITY REACTION 315 0.0232
73 FAECES HARD 66 0.0231
74 CONSTIPATION 3753 0.0226
75 METASTASES TO LYMPH NODES 114 0.0226
76 MEAN PLATELET VOLUME DECREASED 14 0.0224
77 HAEMATOCRIT DECREASED 388 0.0223
78 FULL BLOOD COUNT DECREASED 339 0.0218
79 PERITONEAL DISORDER 12 0.0218
80 PLATELET COUNT ABNORMAL 101 0.0218
81 COLOSTOMY 32 0.0215
82 MYELOSUPPRESSION 246 0.0210
83 HORMONE-REFRACTORY PROSTATE CANCER 17 0.0208
84 LABORATORY TEST ABNORMAL 491 0.0207
85 NEAR DEATH EXPERIENCE 42 0.0206
86 HAEMOGLOBIN DECREASED 1710 0.0199
87 RENAL FUNCTION TEST ABNORMAL 68 0.0195
88 FOOD AVERSION 22 0.0194
89 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 14 0.0194
90 PERFORMANCE STATUS DECREASED 74 0.0188
91 CARBOHYDRATE ANTIGEN 15-3 INCREASED 10 0.0187
92 SOCIAL PROBLEM 60 0.0185
93 BLOOD TEST ABNORMAL 200 0.0185
94 INTRA-ABDOMINAL FLUID COLLECTION 24 0.0185
95 METASTASIS 101 0.0180
96 MASTECTOMY 24 0.0179
97 FLUID INTAKE REDUCED 68 0.0178
98 HAEMATOTOXICITY 116 0.0177
99 BONE MARROW DISORDER 42 0.0175
100 BLOOD PRESSURE INCREASED 2167 0.0173
101 SARS-COV-2 TEST NEGATIVE 10 0.0172
102 ABDOMINAL MASS 35 0.0171
103 INCISIONAL HERNIA 20 0.0170
104 HERNIA REPAIR 35 0.0168
105 HOSPICE CARE 121 0.0166
106 LARGE INTESTINAL OBSTRUCTION 27 0.0162
107 HEPATIC MASS 24 0.0162
108 HEPATIC NEOPLASM 44 0.0161
109 ABDOMINAL LYMPHADENOPATHY 10 0.0159
110 MAGNETIC RESONANCE IMAGING ABNORMAL 12 0.0158
111 BLOOD UREA ABNORMAL 11 0.0157
112 GLOMERULAR FILTRATION RATE DECREASED 134 0.0157
113 APPETITE DISORDER 76 0.0155
114 HAEMOGLOBIN ABNORMAL 75 0.0154
115 PELVIC DISCOMFORT 12 0.0154
116 WHITE BLOOD CELL COUNT DECREASED 1348 0.0154
117 NEUTROPHIL COUNT DECREASED 471 0.0154
118 METASTASES TO LIVER 210 0.0152
119 NEUROPATHY PERIPHERAL 1086 0.0150
120 LYMPHANGIOSIS CARCINOMATOSA 13 0.0149
121 PETECHIAE 125 0.0145
122 HEPATIC LESION 50 0.0145
123 BLOOD PRESSURE DIASTOLIC INCREASED 51 0.0145
124 INTESTINAL OBSTRUCTION 401 0.0140
125 METASTASES TO CENTRAL NERVOUS SYSTEM 134 0.0139
126 ANAEMIA 2176 0.0137
127 ACUTE LEUKAEMIA 19 0.0136
128 HEART RATE INCREASED 1095 0.0136
129 ABDOMINAL HERNIA 51 0.0133
130 BLOOD PRESSURE FLUCTUATION 271 0.0132
131 BLOOD CREATINE INCREASED 48 0.0132
132 THYROID HORMONES INCREASED 10 0.0132
133 RETCHING 224 0.0131
134 MACROCYTOSIS 13 0.0131
135 MALIGNANT PLEURAL EFFUSION 18 0.0130
136 PHARYNGEAL ULCERATION 14 0.0130
137 GASTROINTESTINAL MOTILITY DISORDER 53 0.0130
138 TERMINAL INSOMNIA 14 0.0128
139 MIDDLE INSOMNIA 184 0.0126
140 ILEUS 121 0.0125
141 TRANSFUSION 110 0.0125
142 BLOOD ELECTROLYTES DECREASED 13 0.0124
143 MEAN CELL HAEMOGLOBIN DECREASED 18 0.0124
144 PLATELET TRANSFUSION 12 0.0124
145 ENERGY INCREASED 63 0.0123
146 COLON NEOPLASM 10 0.0122
147 REFLUX GASTRITIS 11 0.0122
148 DRY MOUTH 781 0.0121
149 THROMBOCYTOPENIA 1074 0.0121
150 NAIL GROWTH ABNORMAL 11 0.0120
151 HAEMATOCRIT ABNORMAL 12 0.0120
152 ADVERSE DRUG REACTION 785 0.0119
153 METASTASES TO MENINGES 19 0.0119
154 BOWEL MOVEMENT IRREGULARITY 68 0.0119
155 COLONOSCOPY 20 0.0118
156 DISEASE PROGRESSION 1057 0.0117
157 ASCITES 281 0.0116
158 SUNBURN 74 0.0115
159 BLOOD CREATININE ABNORMAL 30 0.0114
160 BLOOD CREATININE DECREASED 28 0.0114
161 WHITE BLOOD CELL COUNT ABNORMAL 57 0.0113
162 INSOMNIA 2511 0.0113
163 PRODUCT DOSE OMISSION ISSUE 1579 0.0111
164 SMALL INTESTINAL OBSTRUCTION 108 0.0111
165 FULL BLOOD COUNT INCREASED 10 0.0111
166 RED BLOOD CELL COUNT INCREASED 24 0.0110
167 HAIR GROWTH ABNORMAL 63 0.0110
168 NAIL DISCOLOURATION 35 0.0109
169 ILEOSTOMY 18 0.0109
170 GASTROINTESTINAL WALL THICKENING 11 0.0109
171 BLOOD CREATININE INCREASED 596 0.0108
172 PRODUCT DIFFICULT TO SWALLOW 11 0.0108
173 STOMATITIS 517 0.0108
174 BONE MARROW TOXICITY 13 0.0108
175 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 13 0.0108
176 NODULE 112 0.0106
177 DECREASED APPETITE 1913 0.0106
178 TONGUE DISCOMFORT 33 0.0104
179 TUMOUR PAIN 11 0.0103
180 METASTASES TO LUNG 91 0.0102
181 RENAL IMPAIRMENT 675 0.0102
182 ERUCTATION 135 0.0101
183 INITIAL INSOMNIA 77 0.0100
184 LYMPHOEDEMA 54 0.0100
185 SLEEP DISORDER 529 0.0100
186 BLOOD PRESSURE ABNORMAL 148 0.0098
187 ANAEMIA MACROCYTIC 17 0.0098
188 ORAL PAIN 183 0.0097
189 NEOPLASM PROGRESSION 281 0.0097
190 CARCINOEMBRYONIC ANTIGEN INCREASED 14 0.0097
191 BLOOD IRON DECREASED 83 0.0095
192 PROSTATIC SPECIFIC ANTIGEN INCREASED 107 0.0094
193 BLOOD POTASSIUM DECREASED 234 0.0094
194 UPPER-AIRWAY COUGH SYNDROME 59 0.0094
195 PULMONARY MASS 109 0.0094
196 MILIARIA 12 0.0094
197 NAUSEA 5947 0.0093
198 DYSPNOEA EXERTIONAL 269 0.0093
199 NEOPLASM 84 0.0093
200 INTESTINAL MASS 10 0.0092
201 STENT PLACEMENT 63 0.0092
202 WHITE BLOOD CELL DISORDER 20 0.0090
203 METASTASES TO BONE 110 0.0090
204 FEEDING DISORDER 122 0.0090
205 THYROID MASS 25 0.0090
206 EMERGENCY CARE 17 0.0088
207 GASTROINTESTINAL STOMA COMPLICATION 11 0.0088
208 CYTOPENIA 67 0.0088
209 BLOOD SODIUM DECREASED 135 0.0088
210 SUBILEUS 16 0.0087
211 HERNIA 132 0.0087
212 GINGIVAL BLEEDING 90 0.0086
213 FATIGUE 5302 0.0086
214 CHANGE OF BOWEL HABIT 15 0.0086
215 CARDIAC FLUTTER 45 0.0085
216 NEUTROPHIL COUNT ABNORMAL 18 0.0084
217 BLOOD CHLORIDE DECREASED 19 0.0084
218 CANCER PAIN 16 0.0083
219 BONE MARROW FAILURE 154 0.0082
220 PANCYTOPENIA 360 0.0081
221 ILLNESS 390 0.0079
222 METASTATIC NEOPLASM 27 0.0079
223 VITAMIN B12 DECREASED 17 0.0078
224 DENTAL CARE 12 0.0078
225 INTERSTITIAL LUNG DISEASE 294 0.0078
226 DYSPEPSIA 614 0.0078
227 EARLY SATIETY 12 0.0078
228 PROSTATE CANCER METASTATIC 21 0.0077
229 BREAST CANCER RECURRENT 19 0.0077
230 POOR QUALITY SLEEP 128 0.0077
231 INFREQUENT BOWEL MOVEMENTS 15 0.0076
232 LIP PAIN 18 0.0076
233 PIGMENTATION DISORDER 37 0.0075
234 VOLVULUS 13 0.0074
235 HEART RATE ABNORMAL 32 0.0074
236 ABDOMINAL RIGIDITY 16 0.0074
237 DENTAL OPERATION 13 0.0074
238 BLOOD UREA INCREASED 109 0.0074
239 ORAL MUCOSAL BLISTERING 39 0.0074
240 NAIL DISORDER 46 0.0074
241 ONYCHOCLASIS 40 0.0073
242 LYMPHADENOPATHY 211 0.0073
243 TRIGGER FINGER 23 0.0073
244 ILL-DEFINED DISORDER 255 0.0072
245 PROTEIN URINE PRESENT 29 0.0072
246 APLASIA PURE RED CELL 20 0.0072
247 BLOOD IRON INCREASED 11 0.0071
248 MOTION SICKNESS 11 0.0071
249 FLATULENCE 316 0.0070
250 GASTRIC INFECTION 21 0.0070
251 HYPERTENSION 1192 0.0069
252 PARANASAL SINUS DISCOMFORT 19 0.0069
253 ADHESION 9 0.0069
254 DRY THROAT 56 0.0068
255 BLOOD BLISTER 18 0.0068
256 MONOCYTE COUNT INCREASED 19 0.0068
257 INCREASED TENDENCY TO BRUISE 54 0.0068
258 METASTASES TO SPINE 17 0.0067
259 GENE MUTATION 10 0.0067
260 BLOOD DISORDER 44 0.0067
261 PNEUMONITIS 132 0.0066
262 NOCTURIA 61 0.0066
263 PAROSMIA 40 0.0065
264 HOT FLUSH 368 0.0065
265 RENAL MASS 11 0.0065
266 UNDERDOSE 378 0.0064
267 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 210 0.0064
268 MASS 75 0.0064
269 HYDRONEPHROSIS 39 0.0064
270 BRAIN NEOPLASM 46 0.0063
271 ABDOMINAL DISCOMFORT 836 0.0063
272 ASTHENIA 1910 0.0063
273 DERMATOMYOSITIS 12 0.0063
274 INTENTIONAL DOSE OMISSION 73 0.0062
275 CONTUSION 481 0.0062
276 ORAL SURGERY 11 0.0061
277 DIZZINESS POSTURAL 43 0.0061
278 ABDOMINAL DISTENSION 498 0.0060
279 SECOND PRIMARY MALIGNANCY 41 0.0060
280 TONGUE DISCOLOURATION 24 0.0060
281 BONE PAIN 291 0.0060
282 MOUTH HAEMORRHAGE 35 0.0060
283 SEASONAL ALLERGY 60 0.0060
284 LYMPHOCYTE COUNT INCREASED 15 0.0059
285 OROPHARYNGEAL DISCOMFORT 35 0.0059
286 VITAMIN D DECREASED 42 0.0059
287 URINE ODOUR ABNORMAL 29 0.0058
288 MACULE 13 0.0058
289 DEATH 4001 0.0058
290 ANIMAL BITE 12 0.0058
291 FRUSTRATION TOLERANCE DECREASED 35 0.0058
292 PALPITATIONS 554 0.0058
293 TUMOUR HAEMORRHAGE 13 0.0057
294 VOMITING 2150 0.0057
295 FAECALOMA 24 0.0057
296 TONGUE BLISTERING 11 0.0057
297 BLOOD PRESSURE SYSTOLIC INCREASED 89 0.0057
298 INGROWING NAIL 11 0.0056
299 PRODUCT USE COMPLAINT 51 0.0056
300 DEHYDRATION 621 0.0056
301 SPONDYLITIS 15 0.0056
302 GASTROINTESTINAL SOUNDS ABNORMAL 20 0.0056
303 REGURGITATION 15 0.0055
304 OBSTRUCTION 16 0.0055
305 HAEMOGLOBIN INCREASED 17 0.0055
306 DRUG TOLERANCE DECREASED 10 0.0055
307 LEUKAEMIA 42 0.0054
308 SINUS DISORDER 87 0.0054
309 ABDOMINAL ADHESIONS 15 0.0054
310 GASTROINTESTINAL OBSTRUCTION 10 0.0054
311 URINE ANALYSIS ABNORMAL 14 0.0054
312 BLOOD CALCIUM INCREASED 39 0.0053
313 MULTIPLE ALLERGIES 32 0.0053
314 TEMPERATURE INTOLERANCE 42 0.0053
315 FOOD CRAVING 16 0.0053
316 PULMONARY THROMBOSIS 46 0.0053
317 PRODUCT DOSE OMISSION 353 0.0053
318 PLATELET COUNT INCREASED 56 0.0053
319 DYSGEUSIA 339 0.0053
320 THIRST 76 0.0052
321 EATING DISORDER 92 0.0052
322 HEART RATE IRREGULAR 103 0.0052
323 MUSCULOSKELETAL DISCOMFORT 72 0.0052
324 ABDOMINAL PAIN UPPER 848 0.0052
325 HOSPITALISATION 568 0.0051
326 SURGERY 213 0.0051
327 FAECES SOFT 24 0.0051
328 BONE LESION 15 0.0051
329 DYSCHEZIA 10 0.0050
330 AGEUSIA 103 0.0050
331 RENAL DISORDER 192 0.0050
332 RESTLESS LEGS SYNDROME 76 0.0050
333 DRUG INTOLERANCE 365 0.0049
334 GINGIVAL PAIN 32 0.0049
335 TONGUE ULCERATION 14 0.0049
336 FOOD POISONING 19 0.0049
337 FOOD INTOLERANCE 14 0.0048
338 APHTHOUS ULCER 26 0.0048
339 TACHYPHRENIA 14 0.0048
340 HEPATIC ENZYME ABNORMAL 19 0.0048
341 BLOOD POTASSIUM INCREASED 64 0.0047
342 ENDODONTIC PROCEDURE 10 0.0047
343 CREATININE RENAL CLEARANCE DECREASED 17 0.0047
344 HAEMORRHAGE URINARY TRACT 10 0.0047
345 BALANCE DISORDER 339 0.0047
346 HEPATIC CYST 13 0.0047
347 NIGHT SWEATS 116 0.0046
348 URINE ABNORMALITY 16 0.0046
349 MUSCLE FATIGUE 15 0.0046
350 TOOTH EXTRACTION 48 0.0046
351 SECRETION DISCHARGE 41 0.0045
352 RHINORRHOEA 227 0.0045
353 PHARYNGEAL SWELLING 27 0.0045
354 THYROID DISORDER 56 0.0045
355 SENSITIVE SKIN 21 0.0045
356 SARS-COV-2 TEST POSITIVE 48 0.0045
357 FEELING JITTERY 74 0.0045
358 ABDOMINAL INFECTION 9 0.0045
359 GASTROOESOPHAGEAL REFLUX DISEASE 286 0.0045
360 ORAL DISORDER 27 0.0045
361 OFF LABEL USE 2585 0.0044
362 LIP DRY 24 0.0044
363 NASAL DRYNESS 22 0.0044
364 MUSCULOSKELETAL CHEST PAIN 55 0.0044
365 HORDEOLUM 12 0.0044
366 LYMPHOCYTE COUNT DECREASED 63 0.0043
367 LIMB DISCOMFORT 109 0.0043
368 ABDOMINAL TENDERNESS 18 0.0043
369 MUSCLE STRAIN 31 0.0043
370 PNEUMOCYSTIS JIROVECII PNEUMONIA 31 0.0043
371 GASTROINTESTINAL TOXICITY 14 0.0043
372 HUNGER 37 0.0043
373 HEAD DISCOMFORT 58 0.0043
374 FLANK PAIN 33 0.0043
375 SCIATICA 49 0.0043
376 VITAMIN B12 DEFICIENCY 13 0.0042
377 GASTROINTESTINAL PAIN 36 0.0042
378 PRODUCT DISTRIBUTION ISSUE 14 0.0042
379 BACK PAIN 810 0.0042
380 STRESS 240 0.0042
381 PAPULE 21 0.0042
382 OROPHARYNGEAL PAIN 312 0.0042
383 CHAPPED LIPS 15 0.0042
384 CATARACT OPERATION 20 0.0042
385 FUNCTIONAL GASTROINTESTINAL DISORDER 12 0.0042
386 HEADACHE 2146 0.0042
387 PLEURAL EFFUSION 211 0.0042
388 VULVOVAGINAL DRYNESS 11 0.0042
389 BLOOD URINE PRESENT 67 0.0042
390 WEIGHT DECREASED 939 0.0041
391 ABDOMINAL PAIN LOWER 87 0.0041
392 URINARY TRACT INFECTION 549 0.0041
393 BLOOD ALKALINE PHOSPHATASE INCREASED 88 0.0041
394 TEARFULNESS 15 0.0040
395 MYALGIA 565 0.0040
396 GLOSSITIS 12 0.0040
397 ERYTHEMA NODOSUM 11 0.0040
398 PERIPHERAL COLDNESS 46 0.0040
399 SINUS HEADACHE 21 0.0040
400 NEURALGIA 76 0.0040
401 DYSPHAGIA 297 0.0040
402 PRODUCT USE IN UNAPPROVED INDICATION 641 0.0040
403 DISEASE COMPLICATION 15 0.0039
404 HAEMORRHAGE SUBCUTANEOUS 12 0.0039
405 FEELING ABNORMAL 811 0.0039
406 EPISTAXIS 240 0.0039
407 ONYCHOMADESIS 10 0.0039
408 CANDIDA INFECTION 48 0.0038
409 EMOTIONAL DISTRESS 429 0.0038
410 BRUXISM 17 0.0038
411 THERAPY CHANGE 24 0.0038
412 COGNITIVE DISORDER 144 0.0038
413 SUSPECTED COVID-19 11 0.0038
414 SLUGGISHNESS 32 0.0038
415 WALKING AID USER 19 0.0038
416 GINGIVAL SWELLING 14 0.0038
417 GASTROENTERITIS VIRAL 52 0.0037
418 DIZZINESS 1518 0.0037
419 ABNORMAL FAECES 24 0.0037
420 ABDOMINAL PAIN 698 0.0037
421 ARTHROPOD BITE 22 0.0037
422 GLOSSODYNIA 62 0.0037
423 SKIN DISCOLOURATION 140 0.0037
424 ARTHRALGIA 1176 0.0036
425 SALIVARY HYPERSECRETION 29 0.0036
426 DYSPHONIA 169 0.0036
427 TONGUE DISORDER 23 0.0036
428 LIVER FUNCTION TEST INCREASED 53 0.0036
429 PARANASAL SINUS HYPERSECRETION 12 0.0036
430 PERIPHERAL SWELLING 422 0.0036
431 PROTEIN TOTAL DECREASED 11 0.0036
432 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 376 0.0035
433 MUCOSAL INFLAMMATION 73 0.0035
434 NERVOUSNESS 160 0.0035
435 PELVIC PAIN 52 0.0034
436 BLOOD CHOLESTEROL INCREASED 129 0.0034
437 PULMONARY TOXICITY 17 0.0034
438 B-CELL LYMPHOMA 10 0.0034
439 GAIT INABILITY 75 0.0034
440 COUGH 745 0.0034
441 MICTURITION DISORDER 10 0.0034
442 ELECTROCARDIOGRAM ABNORMAL 23 0.0034
443 HYPERSOMNIA 78 0.0034
444 EPIGASTRIC DISCOMFORT 11 0.0034
445 ANXIETY 805 0.0034
446 FAILURE TO THRIVE 15 0.0033
447 DRUG RESISTANCE 66 0.0033
448 NASAL CONGESTION 148 0.0033
449 ORAL DISCOMFORT 38 0.0033
450 BLOOD CALCIUM DECREASED 31 0.0033
451 CYST 33 0.0033
452 BREAST MASS 18 0.0032
453 CYSTITIS 88 0.0032
454 BLOOD CHOLESTEROL ABNORMAL 12 0.0032
455 SUPRAVENTRICULAR TACHYCARDIA 26 0.0032
456 TENSION HEADACHE 11 0.0032
457 THYROID FUNCTION TEST ABNORMAL 12 0.0032
458 NERVE COMPRESSION 24 0.0032
459 HYPOMAGNESAEMIA 34 0.0032
460 INCREASED APPETITE 43 0.0032
461 ENTERITIS 15 0.0032
462 MALAISE 1176 0.0032
463 POSTOPERATIVE WOUND INFECTION 17 0.0032
464 NEUTROPENIA 327 0.0032
465 KIDNEY INFECTION 50 0.0032
466 THERAPY CESSATION 124 0.0032
467 SNEEZING 54 0.0032
468 PRODUCT PRESCRIBING ISSUE 25 0.0031
469 RENAL PAIN 27 0.0031
470 HEPATIC ENZYME INCREASED 164 0.0031
471 EAR PAIN 49 0.0031
472 DYSPNOEA 1430 0.0031
473 ORAL INFECTION 10 0.0031
474 RENAL CYST 21 0.0031
475 MUSCLE SPASMS 468 0.0031
476 DYSURIA 95 0.0031
477 THROMBOSIS 207 0.0031
478 SERUM FERRITIN INCREASED 13 0.0031
479 ARTHRITIS 195 0.0031
480 HYPOPHAGIA 61 0.0031
481 TERMINAL STATE 17 0.0031
482 POLLAKIURIA 104 0.0031
483 PRODUCTIVE COUGH 108 0.0030
484 PROCTALGIA 16 0.0030
485 PSYCHOMOTOR HYPERACTIVITY 44 0.0030
486 GASTRITIS 66 0.0030
487 VITREOUS FLOATERS 22 0.0030
488 HAEMORRHOIDS 49 0.0030
489 BRAIN NEOPLASM MALIGNANT 12 0.0030
490 EMBOLISM 21 0.0030
491 SKIN LACERATION 23 0.0030
492 HYPOAESTHESIA 364 0.0029
493 MUSCULAR WEAKNESS 272 0.0029
494 MEMORY IMPAIRMENT 330 0.0029
495 BREAST CANCER METASTATIC 25 0.0029
496 SKIN DISORDER 76 0.0029
497 NASOPHARYNGITIS 414 0.0029
498 INTESTINAL RESECTION 12 0.0029
499 GASTROINTESTINAL INFECTION 20 0.0029
500 EAR DISCOMFORT 23 0.0028
501 TENDERNESS 25 0.0028
502 EMOTIONAL DISORDER 74 0.0028
503 ODYNOPHAGIA 13 0.0028
504 TOOTH INFECTION 30 0.0028
505 GLUCOSE TOLERANCE IMPAIRED 13 0.0028
506 BREAST PAIN 26 0.0028
507 GASTROINTESTINAL DISORDER 170 0.0028
508 EXTRASYSTOLES 17 0.0028
509 FEELING COLD 64 0.0028
510 MADAROSIS 30 0.0028
511 HYPERCHLORHYDRIA 15 0.0027
512 RESPIRATION ABNORMAL 14 0.0027
513 TACHYCARDIA 198 0.0027
514 PAIN IN EXTREMITY 677 0.0027
515 THERAPEUTIC RESPONSE UNEXPECTED 103 0.0027
516 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0027
517 HIATUS HERNIA 30 0.0027
518 IMMUNE SYSTEM DISORDER 28 0.0027
519 HYPERKERATOSIS 12 0.0027
520 PANCREATIC DISORDER 10 0.0027
521 HAEMOLYTIC ANAEMIA 20 0.0027
522 INTENTIONAL PRODUCT MISUSE 186 0.0026
523 TOOTHACHE 39 0.0026
524 NEPHROPATHY TOXIC 22 0.0026
525 CONDITION AGGRAVATED 591 0.0026
526 BLOOD THYROID STIMULATING HORMONE INCREASED 20 0.0026
527 NEUTROPENIC SEPSIS 16 0.0026
528 NECK PAIN 119 0.0026
529 FORMICATION 16 0.0026
530 PRODUCT USE ISSUE 372 0.0026
531 APLASTIC ANAEMIA 11 0.0026
532 DIARRHOEA 1293 0.0026
533 LOCALISED OEDEMA 10 0.0026
534 SPINAL PAIN 24 0.0026
535 HYPERTENSIVE CRISIS 24 0.0026
536 IMPAIRED QUALITY OF LIFE 25 0.0026
537 NASAL DISCOMFORT 17 0.0025
538 CATARACT 116 0.0025
539 DRY EYE 81 0.0025
540 HYPERHIDROSIS 274 0.0025
541 GASTRIC DISORDER 87 0.0025
542 COVID-19 308 0.0025
543 EXOSTOSIS 18 0.0025
544 HERPES ZOSTER 117 0.0025
545 CEREBRAL DISORDER 14 0.0025
546 FEELING OF BODY TEMPERATURE CHANGE 12 0.0025
547 JOINT STIFFNESS 53 0.0025
548 FEELING HOT 126 0.0025
549 WHITE BLOOD CELL COUNT INCREASED 80 0.0025
550 LIGAMENT SPRAIN 19 0.0024
551 CARDIAC VALVE DISEASE 12 0.0024
552 TOOTH DISORDER 46 0.0024
553 PRURITUS 660 0.0024
554 MICTURITION URGENCY 22 0.0024
555 EXERCISE TOLERANCE DECREASED 11 0.0024
556 GLYCOSYLATED HAEMOGLOBIN INCREASED 47 0.0024
557 OSTEOPENIA 31 0.0024
558 THROAT IRRITATION 83 0.0024
559 IMMUNODEFICIENCY 24 0.0024
560 OESOPHAGITIS 21 0.0024
561 KNEE OPERATION 16 0.0023
562 RASH PRURITIC 99 0.0023
563 LUNG DISORDER 90 0.0023
564 WRIST FRACTURE 23 0.0023
565 HIP ARTHROPLASTY 26 0.0023
566 JOINT INJURY 40 0.0023
567 ALOPECIA 378 0.0023
568 ORAL CANDIDIASIS 23 0.0023
569 DISCOMFORT 102 0.0023
570 CRYING 73 0.0023
571 GAIT DISTURBANCE 365 0.0023
572 SINUSITIS 190 0.0023
573 COLON CANCER 28 0.0023
574 NEOPLASM MALIGNANT 119 0.0023
575 RASH MACULAR 61 0.0023
576 SINUS CONGESTION 25 0.0023
577 BACK DISORDER 30 0.0022
578 HYSTERECTOMY 15 0.0022
579 TREMOR 311 0.0022
580 INTRACRANIAL PRESSURE INCREASED 10 0.0022
581 HEPATIC CYTOLYSIS 10 0.0022
582 DRY SKIN 216 0.0022
583 INTESTINAL PERFORATION 20 0.0022
584 CHROMATURIA 42 0.0022
585 DEPRESSED MOOD 92 0.0022
586 LETHARGY 106 0.0022
587 GINGIVITIS 10 0.0022
588 RECTAL HAEMORRHAGE 79 0.0022
589 THERAPY PARTIAL RESPONDER 15 0.0022
590 LEUKOPENIA 87 0.0022
591 TINNITUS 82 0.0022
592 BLOOD GLUCOSE INCREASED 350 0.0022
593 TOOTH ABSCESS 19 0.0022
594 HICCUPS 14 0.0022
595 UROSEPSIS 16 0.0022
596 BLOOD PRESSURE DECREASED 117 0.0022
597 PNEUMONIA BACTERIAL 14 0.0022
598 COLITIS 60 0.0022
599 HAEMATOCHEZIA 92 0.0021
600 SPINAL OSTEOARTHRITIS 16 0.0021
601 MIGRAINE 159 0.0021
602 LARYNGITIS 18 0.0021
603 BLOOD GLUCOSE FLUCTUATION 20 0.0021
604 INCREASED UPPER AIRWAY SECRETION 10 0.0021
605 HERPES VIRUS INFECTION 10 0.0021
606 URINE OUTPUT DECREASED 16 0.0021
607 BLOOD BILIRUBIN INCREASED 49 0.0021
608 OCULAR DISCOMFORT 15 0.0021
609 BLOOD ALBUMIN DECREASED 14 0.0021
610 DYSSTASIA 52 0.0021
611 TENDONITIS 28 0.0021
612 THERAPY INTERRUPTED 68 0.0021
613 BEDRIDDEN 23 0.0021
614 PULMONARY OEDEMA 78 0.0021
615 LIVER DISORDER 74 0.0021
616 HEPATIC FUNCTION ABNORMAL 60 0.0021
617 HEAD INJURY 53 0.0021
618 LIMB INJURY 44 0.0021
619 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 15 0.0021
620 LYMPHOMA 27 0.0021
621 ASPARTATE AMINOTRANSFERASE INCREASED 92 0.0021
622 MOUTH ULCERATION 34 0.0021
623 OSTEOPOROSIS 71 0.0021
624 HIP FRACTURE 53 0.0021
625 INFLAMMATION 79 0.0020
626 RETINAL DETACHMENT 15 0.0020
627 ALANINE AMINOTRANSFERASE INCREASED 105 0.0020
628 HYPOTHYROIDISM 50 0.0020
629 UNEVALUABLE EVENT 133 0.0020
630 GROIN PAIN 15 0.0020
631 GASTROINTESTINAL INFLAMMATION 12 0.0020
632 SCAR 29 0.0020
633 DISEASE RECURRENCE 67 0.0020
634 SCAB 18 0.0020
635 VISION BLURRED 219 0.0020
636 NEUTROPHIL COUNT INCREASED 17 0.0020
637 PARAESTHESIA 266 0.0020
638 POLYNEUROPATHY 18 0.0020
639 MUSCLE TIGHTNESS 27 0.0020
640 PAIN 1019 0.0020
641 VIRAL INFECTION 50 0.0020
642 CHEST DISCOMFORT 159 0.0020
643 ADVERSE REACTION 21 0.0020
644 PROTEINURIA 28 0.0020
645 HYPOKINESIA 24 0.0020
646 ABNORMAL DREAMS 48 0.0020
647 RASH 658 0.0019
648 DEAFNESS 40 0.0019
649 QUALITY OF LIFE DECREASED 21 0.0019
650 PHOTOPSIA 10 0.0019
651 LYMPHOPENIA 21 0.0019
652 MUSCLE ATROPHY 18 0.0019
653 VERTIGO 96 0.0019
654 CHILLS 182 0.0019
655 PURPURA 14 0.0019
656 FAECES DISCOLOURED 34 0.0019
657 ADVERSE EVENT 141 0.0019
658 ECCHYMOSIS 11 0.0019
659 IRRITABLE BOWEL SYNDROME 29 0.0019
660 PERICARDIAL EFFUSION 34 0.0019
661 HYPERTHYROIDISM 21 0.0019
662 POLYP 10 0.0019
663 FEBRILE NEUTROPENIA 94 0.0018
664 HAEMATURIA 54 0.0018
665 SENSATION OF FOREIGN BODY 12 0.0018
666 ORAL HERPES 27 0.0018
667 CLOSTRIDIUM DIFFICILE INFECTION 30 0.0018
668 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0018
669 INSURANCE ISSUE 11 0.0018
670 EYE DISORDER 47 0.0018
671 EYE INFECTION 15 0.0018
672 EYE HAEMORRHAGE 20 0.0018
673 LACRIMATION INCREASED 39 0.0018
674 RESTLESSNESS 54 0.0018
675 DIVERTICULITIS 39 0.0018
676 FREQUENT BOWEL MOVEMENTS 34 0.0018
677 HAEMORRHAGE 146 0.0018
678 BACK INJURY 14 0.0018
679 URINARY RETENTION 47 0.0017
680 ROTATOR CUFF SYNDROME 19 0.0017
681 SOMNOLENCE 287 0.0017
682 PYELONEPHRITIS 12 0.0017
683 JOINT SWELLING 165 0.0017
684 UPPER LIMB FRACTURE 30 0.0017
685 VISUAL IMPAIRMENT 164 0.0017
686 HAIR TEXTURE ABNORMAL 21 0.0017
687 BLOOD GLUCOSE ABNORMAL 26 0.0017
688 COLD SWEAT 25 0.0017
689 EAR INFECTION 34 0.0017
690 NERVE INJURY 16 0.0017
691 MUSCULOSKELETAL PAIN 81 0.0017
692 INFLUENZA 141 0.0017
693 MUSCULOSKELETAL STIFFNESS 121 0.0017
694 PULMONARY EMBOLISM 139 0.0017
695 APPENDICITIS 12 0.0017
696 SKIN HYPERPIGMENTATION 12 0.0017
697 PULMONARY FIBROSIS 24 0.0017
698 HYPERAESTHESIA 12 0.0017
699 BASAL CELL CARCINOMA 21 0.0017
700 ELECTROLYTE IMBALANCE 15 0.0017
701 RENAL FAILURE 195 0.0017
702 AMNESIA 92 0.0016
703 WEIGHT INCREASED 295 0.0016
704 TRANSIENT ISCHAEMIC ATTACK 48 0.0016
705 HYPERCHOLESTEROLAEMIA 11 0.0016
706 FUNGAL INFECTION 44 0.0016
707 BURNING SENSATION 96 0.0016
708 BODY HEIGHT DECREASED 16 0.0016
709 URINARY INCONTINENCE 40 0.0016
710 VAGINAL HAEMORRHAGE 61 0.0016
711 IMMUNOSUPPRESSION 10 0.0016
712 GALLBLADDER DISORDER 25 0.0016
713 LIVER INJURY 25 0.0016
714 CONFUSIONAL STATE 217 0.0016
715 FALL 436 0.0016
716 HEPATIC STEATOSIS 24 0.0016
717 LUNG INFECTION 25 0.0016
718 PRESYNCOPE 31 0.0016
719 SPINAL COMPRESSION FRACTURE 12 0.0016
720 ESCHERICHIA INFECTION 10 0.0016
721 FRACTURE 25 0.0016
722 DEVICE RELATED INFECTION 21 0.0016
723 HYPOKALAEMIA 58 0.0016
724 DRUG-INDUCED LIVER INJURY 32 0.0016
725 SYNCOPE 131 0.0016
726 INTERNAL HAEMORRHAGE 15 0.0016
727 SQUAMOUS CELL CARCINOMA 12 0.0016
728 ATRIAL FIBRILLATION 125 0.0016
729 LIVER FUNCTION TEST ABNORMAL 41 0.0016
730 PYREXIA 440 0.0016
731 RIB FRACTURE 26 0.0016
732 MYOPATHY 11 0.0015
733 BRAIN OEDEMA 16 0.0015
734 BLADDER DISORDER 13 0.0015
735 HYPONATRAEMIA 72 0.0015
736 NEPHROLITHIASIS 55 0.0015
737 HAEMATEMESIS 33 0.0015
738 FACIAL PAIN 11 0.0015
739 OEDEMA 66 0.0015
740 PHOTOPHOBIA 22 0.0015
741 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 29 0.0015
742 MOVEMENT DISORDER 41 0.0015
743 ULCER 20 0.0015
744 INFECTION 168 0.0015
745 PNEUMOTHORAX 19 0.0015
746 VASCULITIS 14 0.0015
747 VAGINAL DISCHARGE 13 0.0015
748 ANOSMIA 18 0.0015
749 APHASIA 38 0.0015
750 POST PROCEDURAL COMPLICATION 24 0.0015
751 MACULAR DEGENERATION 14 0.0015
752 APHONIA 16 0.0015
753 DERMATITIS CONTACT 13 0.0015
754 DEPRESSION 288 0.0015
755 ATRIAL FLUTTER 10 0.0015
756 BLOOD TRIGLYCERIDES INCREASED 22 0.0015
757 KNEE ARTHROPLASTY 22 0.0015
758 CHOLECYSTITIS 14 0.0015
759 PAIN IN JAW 35 0.0014
760 ATELECTASIS 12 0.0014
761 CHEST PAIN 226 0.0014
762 SKIN CANCER 25 0.0014
763 FOOT FRACTURE 23 0.0014
764 PANIC ATTACK 43 0.0014
765 BLOOD GLUCOSE DECREASED 59 0.0014
766 MUSCLE DISORDER 10 0.0014
767 EYE PRURITUS 32 0.0014
768 HAEMOPTYSIS 33 0.0014
769 RASH PAPULAR 27 0.0014
770 DENTAL CARIES 13 0.0014
771 WEIGHT FLUCTUATION 11 0.0014
772 DRUG ERUPTION 19 0.0014
773 GLAUCOMA 22 0.0014
774 BRONCHITIS 87 0.0014
775 CENTRAL NERVOUS SYSTEM LESION 17 0.0014
776 MOBILITY DECREASED 78 0.0014
777 INCONTINENCE 12 0.0014
778 RASH ERYTHEMATOUS 46 0.0014
779 CHOLELITHIASIS 37 0.0014
780 GENERAL PHYSICAL HEALTH DETERIORATION 115 0.0014
781 TRANSAMINASES INCREASED 25 0.0014
782 SINUS TACHYCARDIA 16 0.0014
783 PROCEDURAL PAIN 29 0.0014
784 INTERVERTEBRAL DISC DEGENERATION 11 0.0013
785 PNEUMONIA 341 0.0013
786 BACTERIAL INFECTION 19 0.0013
787 HYPOTENSION 216 0.0013
788 EPILEPSY 31 0.0013
789 GOUT 19 0.0013
790 ERYTHEMA 219 0.0013
791 HEPATIC FAILURE 33 0.0013
792 COMPLICATION ASSOCIATED WITH DEVICE 14 0.0013
793 TOOTH FRACTURE 12 0.0013
794 DISTURBANCE IN ATTENTION 59 0.0013
795 EXTRA DOSE ADMINISTERED 30 0.0013
796 HYPOAESTHESIA ORAL 16 0.0013
797 BLISTER 56 0.0013
798 SPEECH DISORDER 56 0.0013
799 SPINAL FRACTURE 20 0.0013
800 MALNUTRITION 11 0.0013
801 RASH MACULO-PAPULAR 22 0.0013
802 MOOD ALTERED 28 0.0013
803 FLUID RETENTION 53 0.0013
804 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 89 0.0012
805 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0012
806 PHARYNGITIS 13 0.0012
807 ARTERIOSCLEROSIS 10 0.0012
808 MENTAL IMPAIRMENT 25 0.0012
809 CHOKING 19 0.0012
810 SEPSIS 113 0.0012
811 ADRENAL INSUFFICIENCY 10 0.0012
812 INTERVERTEBRAL DISC PROTRUSION 23 0.0012
813 WOUND 25 0.0012
814 TOXICITY TO VARIOUS AGENTS 161 0.0012
815 PARAESTHESIA ORAL 14 0.0012
816 THINKING ABNORMAL 20 0.0012
817 HYPERSENSITIVITY 184 0.0012
818 PRODUCT DISPENSING ERROR 17 0.0012
819 PHARYNGITIS STREPTOCOCCAL 10 0.0012
820 BODY TEMPERATURE INCREASED 21 0.0012
821 IMPAIRED HEALING 31 0.0012
822 CEREBRAL HAEMORRHAGE 36 0.0012
823 ISCHAEMIC STROKE 18 0.0012
824 DRUG INEFFECTIVE 1275 0.0012
825 PRODUCT PHYSICAL ISSUE 18 0.0012
826 UPPER RESPIRATORY TRACT INFECTION 44 0.0012
827 INFLUENZA LIKE ILLNESS 85 0.0012
828 SWELLING 89 0.0012
829 DRUG INTERACTION 155 0.0012
830 OEDEMA PERIPHERAL 125 0.0012
831 ANKLE FRACTURE 15 0.0012
832 ARRHYTHMIA 47 0.0012
833 INTENTIONAL PRODUCT USE ISSUE 76 0.0012
834 SKIN REACTION 13 0.0012
835 SKIN HAEMORRHAGE 11 0.0012
836 DIPLOPIA 24 0.0012
837 PRODUCT ADMINISTRATION ERROR 15 0.0011
838 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0011
839 PULMONARY CONGESTION 12 0.0011
840 COVID-19 PNEUMONIA 10 0.0011
841 VENTRICULAR EXTRASYSTOLES 10 0.0011
842 PRODUCT TASTE ABNORMAL 12 0.0011
843 DERMATITIS 17 0.0011
844 BACTERAEMIA 10 0.0011
845 HAEMATOMA 25 0.0011
846 ARTHROPATHY 50 0.0011
847 SWOLLEN TONGUE 29 0.0011
848 LEUKOCYTOSIS 16 0.0011
849 HEPATOTOXICITY 19 0.0011
850 LOSS OF CONSCIOUSNESS 116 0.0011
851 NIGHTMARE 32 0.0011
852 MANIA 15 0.0011
853 FIBROMYALGIA 20 0.0011
854 NEUROTOXICITY 14 0.0011
855 HALLUCINATION 63 0.0011
856 MENTAL STATUS CHANGES 25 0.0011
857 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0011
858 CARDIAC DISORDER 85 0.0011
859 DEEP VEIN THROMBOSIS 62 0.0011
860 DIABETES MELLITUS 70 0.0011
861 CARDIAC FAILURE 70 0.0011
862 SUDDEN DEATH 10 0.0011
863 GASTRIC ULCER 17 0.0011
864 PRODUCT AVAILABILITY ISSUE 12 0.0010
865 CARDIOMYOPATHY 13 0.0010
866 CARPAL TUNNEL SYNDROME 12 0.0010
867 CELLULITIS 44 0.0010
868 RESPIRATORY TRACT INFECTION 20 0.0010
869 APATHY 12 0.0010
870 ABSCESS 13 0.0010
871 OXYGEN SATURATION DECREASED 42 0.0010
872 SKIN LESION 21 0.0010
873 OSTEOARTHRITIS 33 0.0010
874 SUBDURAL HAEMATOMA 12 0.0010
875 HYPOXIA 27 0.0010
876 LOCALISED INFECTION 19 0.0010
877 THERAPY NON-RESPONDER 29 0.0010
878 DEMENTIA 20 0.0010
879 HEMIPARESIS 14 0.0010
880 PALLOR 22 0.0010
881 FEAR 23 0.0009
882 SWELLING FACE 50 0.0009
883 DISORIENTATION 32 0.0009
884 AGRANULOCYTOSIS 13 0.0009
885 MUSCLE TWITCHING 18 0.0009
886 HEPATIC CANCER 21 0.0009
887 DRUG DOSE OMISSION 153 0.0009
888 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 20 0.0009
889 LOWER LIMB FRACTURE 13 0.0009
890 SEIZURE 77 0.0009
891 PRESCRIBED UNDERDOSE 14 0.0009
892 SKIN BURNING SENSATION 53 0.0009
893 HEART RATE DECREASED 26 0.0009
894 PAIN OF SKIN 20 0.0009
895 ECZEMA 21 0.0009
896 FLUSHING 77 0.0009
897 DYSARTHRIA 27 0.0009
898 PRODUCT COMPLAINT 13 0.0009
899 PNEUMONIA ASPIRATION 17 0.0009
900 SENSORY DISTURBANCE 12 0.0008
901 EYE PAIN 34 0.0008
902 COAGULOPATHY 12 0.0008
903 GASTROENTERITIS 10 0.0008
904 SKIN ULCER 18 0.0008
905 HYPERGLYCAEMIA 25 0.0008
906 CEREBROVASCULAR ACCIDENT 120 0.0008
907 HEPATITIS 17 0.0008
908 EYE SWELLING 24 0.0008
909 PRODUCT PRESCRIBING ERROR 13 0.0008
910 BONE DISORDER 13 0.0008
911 ACUTE KIDNEY INJURY 93 0.0008
912 URTICARIA 103 0.0008
913 MUSCULOSKELETAL DISORDER 13 0.0008
914 INCORRECT DOSE ADMINISTERED 118 0.0008
915 TREATMENT NONCOMPLIANCE 31 0.0008
916 LIP SWELLING 21 0.0008
917 HEPATIC CIRRHOSIS 11 0.0008
918 ANGINA PECTORIS 19 0.0008
919 PARANOIA 11 0.0008
920 ANGER 22 0.0007
921 HYPERKALAEMIA 21 0.0007
922 DYSKINESIA 25 0.0007
923 HYPOCALCAEMIA 11 0.0007
924 HYPOACUSIS 24 0.0007
925 PHARYNGEAL OEDEMA 11 0.0007
926 PANCREATIC CARCINOMA 19 0.0007
927 IRRITABILITY 37 0.0007
928 ENCEPHALOPATHY 14 0.0007
929 GASTRIC CANCER 17 0.0007
930 FEMUR FRACTURE 19 0.0007
931 AGITATION 44 0.0007
932 ORTHOSTATIC HYPOTENSION 10 0.0007
933 MOOD SWINGS 19 0.0007
934 RESPIRATORY FAILURE 41 0.0007
935 STAPHYLOCOCCAL INFECTION 19 0.0007
936 LUNG NEOPLASM MALIGNANT 24 0.0007
937 WHEEZING 29 0.0007
938 BREAST CANCER 57 0.0007
939 ANGIOEDEMA 23 0.0006
940 LOWER RESPIRATORY TRACT INFECTION 21 0.0006
941 ASTHMA 51 0.0006
942 SEPTIC SHOCK 21 0.0006
943 DELIRIUM 17 0.0006
944 PERITONITIS 11 0.0006
945 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
946 PANCREATITIS ACUTE 11 0.0006
947 CARDIOVASCULAR DISORDER 14 0.0006
948 SKIN EXFOLIATION 38 0.0006
949 GASTROINTESTINAL HAEMORRHAGE 44 0.0006
950 OSTEONECROSIS OF JAW 13 0.0006
951 TYPE 2 DIABETES MELLITUS 16 0.0006
952 C-REACTIVE PROTEIN INCREASED 16 0.0006
953 DRUG HYPERSENSITIVITY 92 0.0006
954 SKIN IRRITATION 22 0.0006
955 PRURITUS GENERALISED 12 0.0006
956 NERVOUS SYSTEM DISORDER 15 0.0005
957 ACUTE MYOCARDIAL INFARCTION 14 0.0005
958 THROAT TIGHTNESS 12 0.0005
959 RESPIRATORY DISORDER 13 0.0005
960 MELAENA 10 0.0005
961 ELECTROCARDIOGRAM QT PROLONGED 15 0.0005
962 TREATMENT FAILURE 32 0.0005
963 RESPIRATORY DISTRESS 12 0.0005
964 CHRONIC KIDNEY DISEASE 36 0.0005
965 EYE IRRITATION 20 0.0005
966 RASH GENERALISED 13 0.0005
967 ROAD TRAFFIC ACCIDENT 17 0.0005
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0005
969 OCULAR HYPERAEMIA 17 0.0005
970 PSYCHOTIC DISORDER 12 0.0005
971 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
972 JAUNDICE 11 0.0005
973 MYOCARDIAL INFARCTION 74 0.0005
974 BLINDNESS 15 0.0005
975 MENTAL DISORDER 16 0.0004
976 CARDIAC FAILURE CONGESTIVE 33 0.0004
977 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
978 ACNE 29 0.0004
979 PANCREATITIS 19 0.0004
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0004
981 BONE DENSITY DECREASED 12 0.0004
982 ACCIDENTAL OVERDOSE 11 0.0004
983 RHABDOMYOLYSIS 13 0.0004
984 PRODUCT STORAGE ERROR 18 0.0004
985 GYNAECOMASTIA 10 0.0003
986 PROSTATE CANCER 26 0.0003
987 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
988 SUICIDAL IDEATION 23 0.0003
989 HYPOGLYCAEMIA 11 0.0003
990 NO ADVERSE EVENT 31 0.0003
991 INJURY 16 0.0003
992 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0003
993 RHEUMATOID ARTHRITIS 22 0.0002
994 CARDIAC ARREST 16 0.0002
995 OVERDOSE 33 0.0002
996 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0002
997 PSORIASIS 15 0.0001
998 PRODUCT QUALITY ISSUE 15 0.0001